Why invest in creating a modifiable drug framework?
Drug Target Review spoke with CUE Biopharma’s President and CSO…
Drug Target Review spoke with CUE Biopharma’s President and CSO to find out how and why they created the ImmunoSTAT platform and the ways it may benefit drug design in the future.